Keiichiro Miyajima

11PUBLICATIONS
15CO-AUTHORS
Other creative arts and writing not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersObstetrics and gynaecologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 25, 2026
Reply by Authors.

|May 22, 2026
First-Line Systemic Treatments of Metastatic Hormone-Sensitive Prostate Cancer: Updated Systematic Review and Network Meta-Analysis.

|Mar 16, 2026
Clinical complete response as a surrogate for pathological response in bladder cancer: a systematic review and meta-analysis.

Navid Roessler, Marcin Miszczyk, Paolo Gontero

|Sep 03, 2024
Transplant renal vein thrombosis and stenosis were rescued by interventional radiology.

Naoki Uchida, Keiichiro Miyajima, Takafumi Yanagiswa

|Jul 22, 2024
Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter study.

Fumihiko Urabe, Yu Imai, Yuma Goto

|Jul 20, 2024
Changes in the treatment landscape of metastatic hormone-sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter study.

Fumihiko Urabe, Katsuki Muramoto, Takafumi Yanagisawa

Pageof 2

Frequent Collaborators

8 joint publications

Fumihiko Urabe

5 joint publications

Shunsuke Tsuzuki

2 joint publications

Wataru Fukuokaya

2 joint publications

Takafumi Yanagisawa